PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-05-08

Date Title Company
08-May-2024 Genflow Biosciences PLC Announces Restoration of Listing AccessWire
08-May-2024 Behavioral Health Market Trends 2024 : Projected to Surpass USD 107.3 Billion Revenue at 7.7% CAGR from 2023-2032 The Wire Times
08-May-2024 Mineral Supplements Market Expected to Reach USD 22.7 Billion by 2033: Growth Rate 4.20% | Marketresearch.biz Wired Release
08-May-2024 Medical Morphine Market Set to Surge to USD 49.8 Billion by 2033: CAGR 7.50% | Marketresearch.biz Wired Release
08-May-2024 Chrysin Extract Market Anticipated to Touch USD 16.4 Million by 2033: CAGR 4.60% | Marketresearch.biz Wired Release
08-May-2024 Cancer Supportive Care Drugs Market Update 2024: Expected to Exhibit USD 25 Billion Revenue by 2032, Claims AMR  The Wire Times
08-May-2024 Envision Pharma Group Announces the Appointment of Alistair Macdonald to Board of Directors Newswire
08-May-2024 Envision Pharma Group Announces the Appointment of Alistair Macdonald to Board of Directors AccessWire
08-May-2024 Fitness App Market Updates: Projected to Cross USD 120.37 by 2030 The Wire Times
08-May-2024 Hyperimmune Globulins Market Projected to Hit USD 4.5 Billion by 2033: CAGR of 6.30% | Marketresearch.biz Wired Release
08-May-2024 Prostaglandin Market to Reach USD 943.9 Million by 2033: Forecasted Growth at 6.50% | Marketresearch.biz Wired Release
08-May-2024 Telehealth Market Updates: Projected to Cross USD 784.3 Billion by 2032 The Wire Times
08-May-2024 iZafe Group Exhibits at Vitalis 2024 - The Future of Health and Welfare Technology AccessWire
08-May-2024 RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter RHÖN-KLINIKUM Aktiengesellschaft
08-May-2024 Nanotechnology Market on a Growth Trajectory: Forecasted to Reach USD 33.63 Billion by 2030 The Wire Times
08-May-2024 APONTIS PHARMA starts financial year 2024 with growth in revenue of Single Pill combinations and positive net result – forecast for full-year 2024 confirmed APONTIS PHARMA AG
08-May-2024 Formycon reports on successful operating business and financial figures for the first quarter of 2024 Formycon AG
08-May-2024 Relief Therapeutics Announces New Executive Leadership Team Strengthening Capabilities to Guide the Company through Pipeline Development Initiatives AccessWire
08-May-2024 IRLAB Publishes Interim Eeport for the Period January-March 2024 AccessWire
08-May-2024 DocMorris AG: Daniel Wüest becomes new CFO at DocMorris DocMorris AG